US Stocks
Immunocore Holdings plc - ADR
Immunocore Holdings plc - ADR

Immunocore Holdings plc - ADR (IMCR)


  • $







Key Stats

Today Low/High$37.38 / $38.68
52 Week Low/High$27.77 / $61.99
Market Cap$1.66B

Company Details

Immunocore is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, infectious and autoimmune. Leveraging its proprietary, flexible, off-the-shelf ImmTAX platform, Immunocore is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. Immunocore’s most advanced oncology therapeutic candidate, tebentafusp, has demonstrated an overall survival benefit in a randomized Phase 3 clinical trial in metastatic uveal melanoma, a cancer that has historically proven to be insensitive to other immunotherapies.
OrganisationImmunocore Holdings plc - ADR

Discover more

Frequently Asked Questions

What is Immunocore Holdings plc - ADR (IMCR) share price today?

Can Indians buy Immunocore Holdings plc - ADR (IMCR) shares?

How can I buy Immunocore Holdings plc - ADR (IMCR) shares from India?

Can Fractional shares of Immunocore Holdings plc - ADR (IMCR) be purchased?

What are the documents required to start investing in Immunocore Holdings plc - ADR (IMCR) stocks?

We are a SEBI registered investement advisor